Claims for Patent: 7,918,833

✉ Email this page to a colleague

Summary for Patent: 7,918,833

Title:	Pen-type injector
Abstract:	The present invention relates to injectors, such as pen-type injectors, that provide for administration of medicinal products from a multidose-cartridge and permit a user to set the delivery dose. The injector may include a housing, a piston rod adapted to operate through the housing, a dose dial sleeve located between the housing and the piston rod, and a drive sleeve located between the dose dial sleeve and the piston rod. The dose dial sleeve may have a helical thread of first lead and the drive sleeve may have a helical groove of second lead. The first lead of the helical thread and the second lead of the helical groove may be the same.
Inventor(s):	Robert Frederick Veasey, Robert Perkins, David Aubrey Plumptre
Assignee:	Sanofi Aventis Deutschland GmbH
Application Number:	US11/483,546

Details for Patent 7,918,833

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Eli Lilly And Company	BASAGLAR	insulin glargine	Injection	205692	December 16, 2015	7,918,833	2026-07-11
Eli Lilly And Company	BASAGLAR	insulin glargine	Injection	205692	November 15, 2019	7,918,833	2026-07-11
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 7,918,833

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
South Africa	200506819	⤷ Get Started Free
South Africa	200506711	⤷ Get Started Free
South Africa	200506658	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	2010084164	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	2004078242	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	2004078241	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.